Updated

Researchers have discovered that recurring arthritis triggered by cancer immunotherapy may be driven by immune cells that remember previous inflammatory attacks and return in a more aggressive state, according to findings published on October 20, 2026. The discovery could pave the way for treatments that prevent painful arthritis flare-ups while preserving the immune system's ability to fight cancer effectively.